The expansion is part of Governor DeSantis' allocation of additional doses of the Moderna vaccine to be administered to individuals ages 65 and older.
Eligible individuals can make appointments using the online reservation system at publix.com/covidvaccine, with vaccinations starting Thursday, Jan. 14.
The announcement brings the total number of Publix pharmacies offering COVID-19 vaccinations to 105 in 12 counties.
Vaccinations are provided to eligible individuals, by appointment only, while supplies last, and at no cost to the individual. Customers with health insurance will need to bring their insurance card to their scheduled appointment.
Customers without health insurance will need to provide their driver's license or Social Security number.
This expansion comes after the company received and distributed its first shipment of vaccines.
Publix continues to communicate with the state of Florida and the other six states in its operating area to provide COVID-19 vaccinations as part of their distribution efforts.
Publix, the largest employee-owned company in the US with more than 225,000 associates, currently operates 1,264 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia.
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio